The purpose of this study is to compare the effectiveness and safety of indacaterol with salmeterol /fluticasone propionate treatment in patients with moderate chronic obstructive pulmonary disease who, on entry to the study are being treated with salmeterol /fluticasone propionate.
Indacaterol is delivered via a SDDPI.
Salmeterol/fluticasone is delivered via a MDDPI
Caba, Argentina, Argentina
Buenos Aires, Buenos Aires, Argentina
Buenos Aires, Buenos Aires, Argentina
Buenos Aires, Buenos Aires, Argentina
Buenos Aires, Buenos Aires, Argentina
C A B A, Buenos Aires, Argentina
Caba, Buenos Aires, Argentina
Caba, Buenos Aires, Argentina
Caba, Buenos Aires, Argentina
Caba, Buenos Aires, Argentina
Caba, Buenos Aires, Argentina
Caba, Buenos Aires, Argentina
Caba, Buenos Aires, Argentina
Caba, Buenos Aires, Argentina
Caba, Buenos Aires, Argentina
Caba, Buenos Aires, Argentina
La Plata, Buenos Aires, Argentina
Mar del Plata, Buenos Aires, Argentina
Mar del Plata, Buenos Aires, Argentina
Quilmes, Buenos Aires, Argentina
Córdoba, Córdoba Province, Argentina
Villa María, Córdoba Province, Argentina
Concepción del Uruguay, Entre Ríos Province, Argentina
Mendoza, Mendoza Province, Argentina
Mendoza, Mendoza Province, Argentina
Santa Fe, Rosario, Argentina
Salta, Salta Province, Argentina
Rosario, Santa Fe Province, Argentina
Santa Fe, Santa Fe Province, Argentina
San Miguel de Tucumán, Tucumán Province, Argentina
San Miguel de Tucumán, Tucumán Province, Argentina
Buenos Aires, Argentina